Seong-Wook Lee
Vermogen: 76 M $ op 31-07-2026
Vermogen: 76 M $ op 31-07-2026
Seong-Wook Lee is the founder of Rznomics, Inc., founded in 2017, serving as Chairman, President & Chief Executive Officer.
The current job is Professor at Dankook University.
Former job includes Independent Director at OliX Pharmaceuticals, Inc. Education includes a doctorate from Cornell University and undergraduate and graduate degrees from Seoul National University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
RZNOMICS INC. 16,12% | 14-07-2026 | 4.491.000 ( 16,12% ) | 76 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RZNOMICS INC. | Algemeen Directeur | 29-08-2017 |
Dankook University
Dankook University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| OLIX PHARMACEUTICALS, INC | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seoul National University
Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dankook University
Dankook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OliX Pharmaceuticals, Inc.
OliX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against locally treatable diseases | Health Technology |
Rznomics Co., Ltd.
Rznomics Co., Ltd. BiotechnologyHealth Technology Develops gene therapies for the treatment of cancer and genetic diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau